Was hat unsere Arbeitsgruppe bereits erforscht?
Im folgenden sind alle abgeschlossenen Projekte der Arbeitsgruppe aufgeführt.
Clinical Microbiology and Infection
Publiziert am 04 Juni 2018
Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study
British Journal of Anasthesia
Publiziert im Oktober 2017
Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days
Critical Care Medicine
Publiziert im Februar 2017
Quality Improvement Initiative for Severe Sepsis and Septic Shock Reduces 90-Day Mortality: A 7.5-Year Observational Study
Intensive Care Medicine
Publiziert am 29 September 2016
Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study
Current Opinion in Anesthesiology
Publiziert im Februar 2018
Vitamin C in sepsis
Implementation Science
Publiziert am 18 Januar 2018
The German Quality Network Sepsis: study protocol for the evaluation of a quality collaborative on decreasing sepsis-related mortality in a quasi-experimental difference-in-differences design
Der Anästehsist
Publiziert am 11 Mai 2017
New Sepsis-3 definition : Do we have to treat sepsis before we can diagnose it from now on?
Intensive Care Medicin
Publiziert am 02 Mai 2017
Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial
JAMA Network
Publiziert am 01 November 2016
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial
Publiziert im September 2016
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial
Publiziert am 27. Februar 2014
Overwhelming postsplenectomy infection syndrome